LOX-1: A potential driver of cardiovascular risk in SLE patients.

LOX-1: A potential driver of cardiovascular risk in SLE patients.

Traditional cardiovascular disease (CVD) risk factors, such as hypertension, dyslipidemia and diabetes do not explain the increased CVD burden in systemic lupus erythematosus (SLE). The oxidized-LDL receptor, LOX-1, is an inflammation-induced receptor implicated in atherosclerotic plaque formation i...

Full description

Bibliographic Details
Main Authors: Divya Sagar, Ranjitha Gaddipati, Emily L Ongstad, Nicholas Bhagroo, Ling-Ling An, Jingya Wang, Mehdi Belkhodja, Saifur Rahman, Zerai Manna, Michael A Davis, Sarfaraz Hasni, Richard Siegel, Miguel Sanjuan, Joseph Grimsby, Roland Kolbeck, Sotirios Karathanasis, Gary P Sims, Ruchi Gupta
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0229184

Internet

https://doi.org/10.1371/journal.pone.0229184

Similar Items